Correlation Between Novartis and Sanofi ADR

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Novartis and Sanofi ADR at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Novartis and Sanofi ADR into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Novartis AG and Sanofi ADR, you can compare the effects of market volatilities on Novartis and Sanofi ADR and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Novartis with a short position of Sanofi ADR. Check out your portfolio center. Please also check ongoing floating volatility patterns of Novartis and Sanofi ADR.

Diversification Opportunities for Novartis and Sanofi ADR

0.85
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Novartis and Sanofi is 0.85. Overlapping area represents the amount of risk that can be diversified away by holding Novartis AG and Sanofi ADR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sanofi ADR and Novartis is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Novartis AG are associated (or correlated) with Sanofi ADR. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sanofi ADR has no effect on the direction of Novartis i.e., Novartis and Sanofi ADR go up and down completely randomly.

Pair Corralation between Novartis and Sanofi ADR

Assuming the 90 days horizon Novartis AG is expected to generate 1.96 times more return on investment than Sanofi ADR. However, Novartis is 1.96 times more volatile than Sanofi ADR. It trades about -0.07 of its potential returns per unit of risk. Sanofi ADR is currently generating about -0.18 per unit of risk. If you would invest  11,605  in Novartis AG on August 30, 2024 and sell it today you would lose (1,335) from holding Novartis AG or give up 11.5% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

Novartis AG  vs.  Sanofi ADR

 Performance 
       Timeline  
Novartis AG 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Novartis AG has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's technical and fundamental indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders.
Sanofi ADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Sanofi ADR has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Novartis and Sanofi ADR Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Novartis and Sanofi ADR

The main advantage of trading using opposite Novartis and Sanofi ADR positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Novartis position performs unexpectedly, Sanofi ADR can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sanofi ADR will offset losses from the drop in Sanofi ADR's long position.
The idea behind Novartis AG and Sanofi ADR pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Other Complementary Tools

Stocks Directory
Find actively traded stocks across global markets
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk